Industry and Geographic Information (Tables)

9 Months Ended

Sep. 30, 2020

Industry And Geographic Information [Abstract]

Sales to Individual Customers in Excess of 10% of Total Revenues

The Company had sales to individual customers in excess of 10% of total revenues, as follows:

	Nine Months Ended September 30,
	2020		2019
Customer:
A	25	%	13	%
B	18	%	17	%
C	11	%	6	%
D	9	%	15	%
Total:	63	%	51	%

Net Revenues by Product Category

Consolidated total revenues by product category for the three and nine months ended September 30, 2020 and 2019 were as follows (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
Rapid Immunoassay	$	337,042	$	42,534	$	513,578	$	126,800
Cardiometabolic Immunoassay	64,810		66,820		172,902		200,674
Specialized Diagnostic Solutions	11,213		12,455		39,452		40,595
Molecular Diagnostic Solutions	62,993		4,683		126,533		14,643
Total revenues	$	476,058	$	126,492	$	852,465	$	382,712